Bayer AG (BAYRY)
5.96
0.06 (1.02%)
At close: Apr 14, 2025, 3:59 PM
1.02% (1D)
Bid | 5.91 |
Market Cap | 23.42B |
Revenue (ttm) | 46.61B |
Net Income (ttm) | -2.55B |
EPS (ttm) | -0.71 |
PE Ratio (ttm) | -8.39 |
Forward PE | n/a |
Analyst | n/a |
Ask | 5.93 |
Volume | 185,216 |
Avg. Volume (20D) | 843,459.1 |
Open | 5.93 |
Previous Close | 5.90 |
Day's Range | 5.89 - 5.96 |
52-Week Range | 4.79 - 8.58 |
Beta | 1.01 |
About BAYRY
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene ther...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Nov 18, 1996
Employees 90,587
Stock Exchange PNK
Ticker Symbol BAYRY
Website https://www.bayer.com
Next Earnings Release
Bayer AG is scheduled to release its earnings on May 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription